New cancer clinical trial: Pilot Study of Biomarkers of Response to Immune Checkpoint Blockade in Metastatic Melanoma

Published on: November 29, 2017 at 10:00AM
Condition:   Melanoma
Intervention:   Other: F-FDG PET/CT
Sponsors:   University of Wisconsin, Madison;   National Cancer Institute (NCI)
Not yet recruiting
http://ift.tt/2Ah7XKO